Evran Sedat
EVRAN SEDAT, EVP, GSC, reported a transaction classified as withholding at BIO-RAD LABORATORIES, INC. involving 329.000000 shares for an estimated $127030.19. Reported holdings after the transaction were 3016.120000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 05, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BIO BIO.B price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001993147-26-000002 Bio-Rad A Common Stock
- Transaction date
- Sep 05, 2026 Filed Sep 09, 2026, 10:46 PM · 4d delay
- Shares
- 329 sh $386.11 per share
- Estimated value
- -$127k Computed from shares × price
- Holdings after
- 3,016.12 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, Global Supply Chain
- F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2
Includes 51.2870 and 33.9860 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026 and 06/30/2026, respectively.
- F3
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F4
The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
- F5
The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
0 other transactions
0 recent txs